149 related articles for article (PubMed ID: 17617651)
1. Factors associated with mortality in patients new to haemodialysis.
Spiegel DM; Raggi P; Smits G; Block GA
Nephrol Dial Transplant; 2007 Dec; 22(12):3568-72. PubMed ID: 17617651
[TBL] [Abstract][Full Text] [Related]
2. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients.
Noordzij M; Cranenburg EM; Engelsman LF; Hermans MM; Boeschoten EW; Brandenburg VM; Bos WJ; Kooman JP; Dekker FW; Ketteler M; Schurgers LJ; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2011 May; 26(5):1662-9. PubMed ID: 20880929
[TBL] [Abstract][Full Text] [Related]
3. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Mason MA; Shepler BM
Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
6. Determinants of progressive vascular calcification in haemodialysis patients.
Chertow GM; Raggi P; Chasan-Taber S; Bommer J; Holzer H; Burke SK
Nephrol Dial Transplant; 2004 Jun; 19(6):1489-96. PubMed ID: 15102961
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
8. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.
Asmus HG; Braun J; Krause R; Brunkhorst R; Holzer H; Schulz W; Neumayer HH; Raggi P; Bommer J
Nephrol Dial Transplant; 2005 Aug; 20(8):1653-61. PubMed ID: 15930018
[TBL] [Abstract][Full Text] [Related]
9. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis.
den Elzen WP; van Manen JG; Boeschoten EW; Krediet RT; Dekker FW
Nephrol Dial Transplant; 2006 Jun; 21(6):1588-95. PubMed ID: 16449284
[TBL] [Abstract][Full Text] [Related]
10. Coronary calcification and its association with mortality in haemodialysis patients.
Fensterseifer DM; Karohl C; Schvartzman P; Costa CA; Veronese FJ
Nephrology (Carlton); 2009 Apr; 14(2):164-70. PubMed ID: 19054332
[TBL] [Abstract][Full Text] [Related]
11. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
[TBL] [Abstract][Full Text] [Related]
12. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
[TBL] [Abstract][Full Text] [Related]
13. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
Terrier N; Jaussent I; Dupuy AM; Morena M; Delcourt C; Chalabi L; Rouanet C; Canaud B; Cristol JP
Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
[TBL] [Abstract][Full Text] [Related]
14. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
Sigrist MK; Taal MW; Bungay P; McIntyre CW
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
[TBL] [Abstract][Full Text] [Related]
15. Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial.
D'Marco LG; Bellasi A; Kim S; Chen Z; Block GA; Raggi P
Nephrol Dial Transplant; 2013 Oct; 28(10):2586-95. PubMed ID: 23904396
[TBL] [Abstract][Full Text] [Related]
16. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
Suki WN;
J Ren Nutr; 2008 Jan; 18(1):91-8. PubMed ID: 18089452
[TBL] [Abstract][Full Text] [Related]
17. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification.
Sigrist MK; Levin A; Er L; McIntyre CW
Nephrol Dial Transplant; 2009 Oct; 24(10):3157-62. PubMed ID: 19491380
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.
Garland JS; Holden RM; Groome PA; Lam M; Nolan RL; Morton AR; Pickett W
Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059
[TBL] [Abstract][Full Text] [Related]
19. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
Martola L; Elinder CG; Stenvinkel P
Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
